04:28 PM EDT, 09/12/2025 (MT Newswires) -- Christopher Gibson, Director, Chief Executive Officer, on September 10, 2025, sold 100,000 shares in Recursion Pharmaceuticals ( RXRX ) for $471,000. Following the Form 4 filing with the SEC, Gibson has control over a total of 974,229 Class A common shares of the company, with 974,229 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1601830/000160183025000145/xslF345X05/wk-form4_1757708640.xml